Back to search
FDAFDA · Food and drugs·Recall number D-1282-2019

Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only GSMS Incorporated

Published May 29, 2019 · Recall initiated: May 1, 2019

Summary

FDA records drug Class II recall D-1282-2019, published May 29, 2019 and initiated May 1, 2019. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 11,668 HDPE bottles; Lot: GS017981 exp 02/2020, GS016958 exp 02/2020, GS017341 exp 02/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Golden State Medical Supply Inc.
Distributor
IL, MI, MN, PA, TN, TX. Two (2) US government and one (1) Veterans Affairs accounts. No foreign accounts.
Lot
GS017981 exp 02/2020, GS016958 exp 02/2020, GS017341 exp 02/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only GSMS Incorporated recalled?

Yes. FDA published recall D-1282-2019 on May 29, 2019. Reported hazard: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit